Mark EB, Nedergaard RB, Hansen TM, et al. Tapentadol results in less deterioration of gastrointestinal function and symptoms than standard opioid therapy in healthy male volunteers [published online ahead of print, 2021 May 29]. Neurogastroenterol Motil. 2021;e14131. doi:10.1111/nmo.14131

Leave a Reply